Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04111939 · ClinicalTrials.gov registry record · NA

HEALing Communities Study

A NA study of Opioid Use Disorder (OUD), sponsored by RTI International.

Active
Registry status
NA
Development phase
67
Enrollment target
4
Study locations

NCT04111939 is a NA study of Opioid Use Disorder (OUD) that is active but no longer recruiting, run by RTI International. The registered enrollment target is 67 participants, below the 308-participant average among 7 other Opioid Use Disorder (OUD) trials with a reported enrollment target (78% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04111939, a NA study of Opioid Use Disorder (OUD), is active but no longer recruiting, sponsored by RTI International.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
67 participants
Enrollment target
4
Study locations

Study Summary

This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goal of reducing opioid overdose deaths by 40%.

Conditions Studied

Interventions

  • OTHER Communities That HEAL
  • OTHER Wait-list control

Study Locations (4)

Kentucky

  • University of Kentucky - Lexington

Massachusetts

  • Boston Medical Center - Boston

New York

  • Columbia University - New York

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2019-10-23
Est. Completion 2025-09-30
Phase NA

Sponsor

RTI International

45 total trials

What the Registry Record Tells You About NCT04111939

The ClinicalTrials.gov registry entry for NCT04111939 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 308-participant average among 7 other Opioid Use Disorder (OUD) trials with a reported enrollment target (78% lower). The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder (OUD) appearing as the primary indexed condition, and to 2 interventions - of which Communities That HEAL is the first listed.

NCT04111939 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Kentucky, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT04111939 about?

NCT04111939 is a clinical study titled "HEALing Communities Study". This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goal of reducing opioid overdose deaths by 40%.

What is the current status of trial NCT04111939?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2019-10-23. Estimated completion is 2025-09-30.

What conditions does trial NCT04111939 study?

This clinical trial studies the following conditions: Opioid Use Disorder (OUD).

What interventions are being tested in trial NCT04111939?

The interventions under investigation include: Communities That HEAL (OTHER), Wait-list control (OTHER).

Who is sponsoring clinical trial NCT04111939?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04111939 being conducted?

This trial has 4 study locations across Kentucky, Massachusetts, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder (OUD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.